Viropharma News
Most Popular Viropharma Story
Wyeth stumbles badly trying to develop new drugs
The analysts have been picking over Wyeth's carcass over the past few days as they assess a string of woeful developments that have left the company stripped of three of its leading drug candidates. Read more...
Latest Headlines
- October 27, 2011
- September 30, 2011
- August 27, 2009
- February 13, 2009
- February 10, 2009
- October 13, 2008
- July 15, 2008
- April 17, 2008
- August 13, 2007
- August 10, 2007
- August 8, 2007
- November 7, 2006
- August 13, 2006
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
